Technologic Considerations of Creation Dosage Form of Original Substance 3,7-diazabicyclo[3.3.1]nonane

Technologic Considerations of Creation Dosage Form of Original Substance 3,7-diazabicyclo[3.3.1]nonane

Introduction. An innovative pharmaceutical substance based on the 3,7-diazabicyclo[3.3.1]nonane derivative provides long-term activation of AMPA receptors and the production of neurotrophic factors, which makes it possible to use it for the treatment of cognitive impairments and rehabilitation of pa...

Full description

Bibliographic Details
Main Authors: G. E. Brkich, N. V. Pyatigorskaya, O. A. Zyryanov, N. B. Demina, E. O. Bakhrushina, I. I. Krasnyuk
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-11-01
Series:Разработка и регистрация лекарственных средств
Subjects:
derivative of the 3,7-diazabicyclononane
pharmaceutical development
dissolution test
ampa receptor modulator
gelatin and hypromellose capsules
Online Access:https://www.pharmjournal.ru/jour/article/view/762

Internet

https://www.pharmjournal.ru/jour/article/view/762

Similar Items